Código QR (código de barras bidimensional)

Safety, tolerability, and pharmacokinetics of TG-1000, a new molecular entity against influenza virus: first-in-human study

Background: The cap-snatching mechanism of influenza virus mRNA transcription is strongly suppressed by TG-1000, a prodrug rapidly metabolized into TG-0527, is a potent cap-dependent nucleic acid endonuclease inhibitor. Herein, we aimed to assess the safety, tolerability, and pharmacokinetics of TG-...

ver descrição completa

Na minha lista:
Principais autores: Su-Mei Xu, Li-Wen Chang, Cheng-Yuan Tsai, Wan-Li Liu, Dai Li, Shan-Shan Li, Xiao-Min Li, Ping-Sheng Xu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2023-11-01
coleção:Frontiers in Pharmacology
Assuntos:
first-in-human
TG-1000
influenza
safety
tolerability
pharmacokinetics
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphar.2023.1272466/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados